רפמיון 1 מ"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

SIROLIMUS 1.00 MG

Dostupné s:

NEOPHARM LTD

ATC kód:

L04AA10

Léková forma:

COATED TABLETS

Podání:

PER OS

Výrobce:

PFIZER IRELAND PHARMACEUTICALS

Terapeutické skupiny:

SIROLIMUS

Terapeutické indikace:

Rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. It is recommended that Rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. Rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Datum autorizace:

2009-10-01